Skip to Main Content

Author Details

Matthias Edinger
Regensburg University Hospital
1994
113
40
PMIDPaper TitleJournal TitlePublished Year
36350750Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use.Blood Adv2023
37777112Incidence and Outcome of Atypical Manifestations of Chronic Graft-versus-Host Disease: Results From a Retrospective Single-Center Analysis.Transplant Cell Ther2023
37259539Intestinal IgA-positive plasma cells are highly sensitive indicators of alloreaction early after allogeneic transplantation and associate with both graft-versus-host disease and relapse-related mortality.Haematologica2023
37420011Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP).Bone Marrow Transplant2023
37386935Restrictive Versus Permissive Use of Broad-spectrum Antibiotics in Patients Receiving Allogeneic Stem Cell Transplantation and With Early Fever Due to Cytokine Release Syndrome: Evidence for Beneficial Microbiota Protection Without Increase in Infectious Complications.Clin Infect Dis2023
37347269Analysis of long-term mortality after total body irradiation-based and melphalan-based chemotherapy conditioning for acute myeloid leukemia.Ann Hematol2023
36883586Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells.Clin Infect Dis2023
36695625Optimum timing of antithymocyte globulin in relation to adoptive regulatory T cell therapy.Am J Transplant2023
36719764Murine cytomegalovirus reactivation concomitant with acute graft-versus-host disease is controlled by antibodies.JCI Insight2023
36914893A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy.Nat Med2023
36698616Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT.Hemasphere2023
34043764Prolonged Suppression of Butyrate-Producing Bacteria Is Associated With Acute Gastrointestinal Graft-vs-Host Disease and Transplantation-Related Mortality After Allogeneic Stem Cell Transplantation.Clin Infect Dis2022
35670780Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis.Clin Cancer Res2022
35572572Low Intestinal IL22 Associates With Increased Transplant-Related Mortality After Allogeneic Stem Cell Transplantation.Front Immunol2022
35851959Apheresis for chimeric antigen receptor T-cell production in adult lymphoma patients.Transfusion2022
36447269Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation.Radiat Oncol2022
36341397Downregulation of the vitamin D receptor expression during acute gastrointestinal graft versus host disease is associated with poor outcome after allogeneic stem cell transplantation.Front Immunol2022
36161919Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy.Proc Natl Acad Sci U S A2022
36051076Unusually swift response of relapsed Burkitt leukemia to R-DHAP.EJHaem2022
34049733Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation - A single center retrospective efficacy analysis.Vaccine2021
33515310Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.Ann Hematol2021
33789089Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells.Immunity2021
33838047Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia.Br J Haematol2021
33585521A Prospective Controlled Trial to Evaluate Safety and Efficacy of <i>in vitro</i> Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001).Front Med (Lausanne)2021
34777363GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics.Front Immunol2021
34595389Human bocavirus 1 respiratory tract reactivations or reinfections in two adults, contributing to neurological deficits and death.Access Microbiol2021
34277549"This Graft-vs.-Host Disease Determines My Life. That's It."-A Qualitative Analysis of the Experiences and Needs of Allogenic Hematopoietic Stem Cells Transplantation Survivors in Germany.Front Public Health2021
34187476A qualitative study on patients' and their support persons' preferences for receiving one longer consultation or two shorter consultations when being informed about allogeneic hematopoietic stem cell transplantation.BMC Health Serv Res2021
34063640Parametric Imaging of Contrast-Enhanced Ultrasound (CEUS) for the Evaluation of Acute Gastrointestinal Graft-Versus-Host Disease.Cells2021
32123937International Regensburg Center for Interventional Immunology (RCI) symposium on "Synthetic immunology and environment-adapted redirection of T cells", 17-18 July, 2019, Regensburg, Germany.Cancer Immunol Immunother2020
32086584IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.Ann Hematol2020
31964861Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1.Nat Commun2020
31924477Precursors for Nonlymphoid-Tissue Treg Cells Reside in Secondary Lymphoid Organs and Are Programmed by the Transcription Factor BATF.Immunity2020
31719679Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells.Leukemia2020
32098963Author Correction: Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1.Nat Commun2020
33072711Evaluation of the Cost of Survivorship Care After Allogeneic Hematopoeitic Stem Cell Transplantation-An Analysis of 2 German Transplantation Centers.Front Public Health2020
32715339Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis.Ann Hematol2020
32446407Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.Lancet2020
32301111Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT.Br J Haematol2020
30514803Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.Haematologica2019
31375860Long-term follow-up of rituximab in treatment of chronic graft-versus-host disease-single center experience.Ann Hematol2019
31633216Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).Eur J Immunol2019
31089288Haploidentical CD3 or α/β T-cell depleted HSCT in advanced stage sickle cell disease.Bone Marrow Transplant2019
29367715Biomarkers in chronic graft-versus-host disease: quo vadis?Bone Marrow Transplant2018
29875316CD83 expression is essential for Treg cell differentiation and stability.JCI Insight2018
27942862Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.Ann Hematol2017
28804124Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.Leukemia2017
28850106FANTOM5 CAGE profiles of human and mouse samples.Sci Data2017
26999608Driving allotolerance: CAR-expressing Tregs for tolerance induction in organ and stem cell transplantation.J Clin Invest2016
26464170Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.Leukemia2016
  • 1 - 50 of 113

Recommended Authors

Sawa Ito
University of Pittsburgh
Career Start Year 2013
Number of shared co-authors 4
Angelika Schmidt
Institute for Immunology, Biomedical Center (BMC)
Career Start Year 2009
Number of shared co-authors 1
Moutih Rafei
Universite de Montreal
Career Start Year 2007
Number of shared co-authors 0
Hyung W Lim
Gladstone Institute of Virology and Immunology
Career Start Year 2004
Number of shared co-authors 0
Jordi Ochando
Icahn School of Medicine at Mount Sinai
Career Start Year 2004
Number of shared co-authors 2
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 0
Marcin Moniuszko
Medical University of Bialystok
Career Start Year 2001
Number of shared co-authors 3
Dorian LaTocha
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2000
Number of shared co-authors 0
Evan F Lind
Oregon Health & Science University
Career Start Year 1999
Number of shared co-authors 0
Peter T Sage
Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1998
Number of shared co-authors 0
Andrew D Wells
Center for Spatial and Functional Genomics, Children's Hospital of Philadelphia
Career Start Year 1996
Number of shared co-authors 0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 2
Francesca Fallarino
University of Perugia
Career Start Year 1995
Number of shared co-authors 1
Cynthia Perez
Loyola University Chicago
Career Start Year 1995
Number of shared co-authors 0
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 2
Jonathan S Serody
The University of North Carolina School of Medicine
Career Start Year 1991
Number of shared co-authors 5
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 3
Volker Eckstein
Heidelberg University
Career Start Year 1990
Number of shared co-authors 1
Clare Baecher-Allan
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1988
Number of shared co-authors 0
Maura Rossetti
University of California Los Angeles
Career Start Year 1986
Number of shared co-authors 0
Denis-Claude Roy
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 1
Su M Metcalfe
University of Cambridge Clinical School, LIFNanoRx Ltd
Career Start Year 1984
Number of shared co-authors 0
Richard T Maziarz
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 1
Penelope A Morel
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 4
Wolfgang Holter
St. Anna Children's Hospital, Medical University of Vienna
Career Start Year 1980
Number of shared co-authors 1
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 5
John F DiPersio
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 4
Ronald E Gress
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 3
Jerome Ritz
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Career Start Year 1976
Number of shared co-authors 4
David W Scott
University of British Columbia
Career Start Year 1965
Number of shared co-authors 2

Collaborators

Michael Rehli
University Hospital Regensburg
Co-authored papers 14
Christian Schmidl
Leibniz Institute for Immunotherapy
Co-authored papers 12
Hideya Kawaji
RIKEN Center for Integrative Medical Sciences
Co-authored papers 4
Yoshihide Hayashizaki
Center for Integrative Medical Sciences
Co-authored papers 4
Masayoshi Itoh
RIKEN Center for Integrative Medical Sciences
Co-authored papers 4
Claudia Gebhard
University Hospital Regensburg
Co-authored papers 4
Harukazu Suzuki
RIKEN Center for Integrative Medical Sciences
Co-authored papers 4
Anne M Dickinson
Translational and Clinical Research Institute, Newcastle University
Co-authored papers 4
Timo Lassmann
Telethon Kids Institute, University of Western Australia
Co-authored papers 4
Piero Carninci
RIKEN Center for Integrative Medical Sciences
Co-authored papers 4
Alistair R R Forrest
RIKEN Center for Integrative Medical Sciences
Co-authored papers 4
Sayaka Nagao-Sato
Ochanomizu University
Co-authored papers 4
David A Hume
Mater Research Institute-UQ, Translational Research Institute
Co-authored papers 3
Jun Kawai
RIKEN Center for Integrative Medical Sciences
Co-authored papers 3
Wolfgang E Berdel
University Hospital Munster
Co-authored papers 3
Piotr J Balwierz
MRC London Institute of Medical Sciences
Co-authored papers 3
Shimon Sakaguchi
Institute for Frontier Medical Sciences, Kyoto University
Co-authored papers 3
Rainer Spang
University of Regensburg
Co-authored papers 3
Tony J Kenna
Queensland University of Technology
Co-authored papers 2
Albert S B Edge
Harvard Medical School
Co-authored papers 2
Christophe Simon
RIKEN Yokohama Institute
Co-authored papers 2
Peter Heutink
German Center for Neurodegenerative Diseases (DZNE).
Co-authored papers 2
Ernst J Wolvetang
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Co-authored papers 2
Suzana Savvi
South African Medical Research Council (SAMRC), University of Cape Town
Co-authored papers 2
Soichi Ogishima
Tohoku University Graduate School of Medicine
Co-authored papers 2
Christine L Mummery
Leiden University Medical Center
Co-authored papers 2
Weonju Lee
Kyungpook National University, Kyungpook National University Hospital
Co-authored papers 2
Yohei Yonekura
RIKEN Center for Developmental Biology
Co-authored papers 2
Carsten O Daub
International Institute of Molecular and Cell Biology in Warsaw
Co-authored papers 2
Noriko Ninomiya
Japan Tobacco Inc.
Co-authored papers 2
Release 1.2